WILZIN 50 mg, hard capsule 250 capsules
Active ingredients: Zinc, Zinc acetate dihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule250 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- WILZIN 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 250 gélule(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- RECORDATI RARE DISEASES
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Feb 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68269313CIP73651761CIP133400936517615Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ZINCgélule | 50 mg · une gélule | FT |
| ZINC (ACÉTATE DE) DIHYDRATÉgélule | 167,84 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.